Adheris Health Limited (AU:AHE) — Market Cap & Net Worth
Market Cap & Net Worth: Adheris Health Limited (AHE)
Adheris Health Limited (AU:AHE) has a market capitalization of $136.67 (AU$193.16) as of May 2, 2026. Listed on the AU stock exchange, this Australia-based company holds position #31480 globally and #1837 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Adheris Health Limited's stock price AU$0.02 by its total outstanding shares 9658 (9.66K). Analyse AHE cash flow metrics to see how efficiently the company converts income to cash.
Adheris Health Limited Market Cap History: 2026 to 2026
Adheris Health Limited's market capitalization history from 2026 to 2026. Data shows growth from $136.67 to $136.67 (0.00% CAGR).
Adheris Health Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Adheris Health Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of AHE by Market Capitalization
Companies near Adheris Health Limited in the global market cap rankings as of May 2, 2026.
Key companies related to Adheris Health Limited by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #926 globally with a market cap of $28.21 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #2225 globally with a market cap of $10.06 Billion USD ( AU$14.22 Billion AUD).
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2339 globally with a market cap of $9.34 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2447 globally with a market cap of $8.82 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #926 | Veeva Systems Inc Class A | NYSE:VEEV | $28.21 Billion | $171.60 |
| #2225 | Pro Medicus Ltd | AU:PME | $10.06 Billion | AU$136.16 |
| #2339 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $9.34 Billion | $55.00 |
| #2447 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $8.82 Billion | $52.58 |
Adheris Health Limited Historical Marketcap From 2026 to 2026
Between 2026 and today, Adheris Health Limited's market cap moved from $136.67 to $ 136.67, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$136.67 | -- |
End of Day Market Cap According to Different Sources
On May 2nd, 2026 the market cap of Adheris Health Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $136.67 USD |
| MoneyControl | $136.67 USD |
| MarketWatch | $136.67 USD |
| marketcap.company | $136.67 USD |
| Reuters | $136.67 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Adheris Health Limited
Adheris Health Limited, together with its subsidiaries, provides pharmacy-driven patient engagement solutions in Australia, the United States, and the United Kingdom. The company offers THRiV, an omni-channel platform which provides pharmacy-driven patient and pharmacist engagement solutions to improve medication management. The company was formerly known as MedAdvisor Limited and changed its anm… Read more